MEI Pharma Research Coverage Started at StockNews.com
| MEIP Stock | USD 2.70 0.10 3.57% |
Slightly above 61% of MEI Pharma's investor base is looking to short. The analysis of the overall investor sentiment regarding MEI Pharma suggests that many traders are alarmed. MEI Pharma's investing sentiment overview a quick insight into current market opportunities from investing in MEI Pharma. Many technical investors use MEI Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
MEI |
StockNews.com began coverage on shares of MEI Pharma in a research report report published on Monday morning. The brokerage issued a buy rating on the stock. MEI Pharma Trading Down 3.6 percent Shares of MEIP stock opened at 2.70 on Monday. The firm has a market capitalization of 17.98 million, a
Read at thelincolnianonline.com
 |
MEI Pharma Fundamental Analysis
We analyze MEI Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MEI Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MEI Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
MEI Pharma is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
MEI Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MEI Pharma stock to make a market-neutral strategy. Peer analysis of MEI Pharma could also be used in its relative valuation, which is a method of valuing MEI Pharma by comparing valuation metrics with similar companies.
Peers
MEI Pharma Related Equities
| ZURA | Zura Bio | 3.64 | ||||
| RNAZ | Transcode Therapeutics | 2.91 | ||||
| TIL | Instil Bio | 2.52 | ||||
| TERN | Terns Pharmaceuticals | 2.12 | ||||
| INZY | Inozyme Pharma | 1.68 | ||||
| ASMB | Assembly Biosciences | 0.20 | ||||
| KZR | Kezar Life | 0.44 | ||||
| DAWN | Day One | 0.47 | ||||
| HOOK | Hookipa Pharma | 0.47 | ||||
| CTMX | CytomX Therapeutics | 0.89 | ||||
| ABOS | Acumen Pharmaceuticals | 1.93 | ||||
| PHIO | Phio Pharmaceuticals | 2.09 | ||||
| OCUL | Ocular Therapeutix | 2.25 | ||||
| SPRO | Spero Therapeutics | 2.73 | ||||
| ZVSA | ZyVersa Therapeutics | 2.78 | ||||
| ACHL | Achilles Therapeutics | 2.94 | ||||
| ATXI | Avenue Therapeutics | 3.23 | ||||
| VINC | Vincerx Pharma | 5.00 | ||||
| REVB | Revelation Biosciences | 12.20 |
Additional Tools for MEI Stock Analysis
When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.